Label dose by age, once daily: 5 mg at 2 to under 6 years and 10 mg from 6 years; under 2 years ask a doctor. The calculator gives a weight-based estimate in mL; check it against the age dose.
Children's Claritin dosing
Loratadine is the generic version of Claritin. These pages help with the label chart, product forms and comparisons with other daily allergy medicines.
See the label age chart for Children's Claritin liquid and chewables.
Review once-daily timing, measuring and product-form details for children.
See how loratadine fits with other common allergy medicines used in kids.
Open cetirizine to compare a closely related daily antihistamine.
Open fexofenadine when the goal is another lower-drowsiness daytime allergy option.
label dose by age
The FDA labels set the loratadine dose by age, not weight. The calculator has no age field: it gives a weight-based estimate, and its caps use a weight band that stands in for age (about 20 kg for 6 years). A child who is heavy or light for their age can get a different dose from the label dose, so always use the age dose.
Calculator: mL per dose = (weight in kg × mg/kg/day), capped by weight band, ÷ 1 mg per mL. Use the label dose for the child's age when it differs.
A 5-year-old weighing 22 kg at 0.25 mg/kg/day: the calculator gives 5.5 mg, more than the 5 mg daily maximum for 2 to under 6 years. A 7-year-old weighing 18 kg: the calculator gives 4.5 mg, but the label dose from 6 years is 10 mg. Use the age dose.
Practical dosing guide
Use this page to match the child's age, product form, and once-daily plan before giving loratadine.
Loratadine (Claritin) pediatric dose by age from the FDA label: 5 mg once daily at 2 to under 6 years and 10 mg once daily from 6 years, with mL for 5 mg/5 mL liquid. Under 2 years, ask a doctor.
Dose by age, once daily: 5 mg at 2 to under 6 years, 10 mg from 6 years (labels).
US liquid is 1 mg/mL (5 mg/5 mL), so each mg is 1 mL. Children's chewables are 5 mg each.
What the US labels cover for loratadine in children, and where guidelines place it.
Hay fever and other upper respiratory allergies: Give once daily.
Hives (urticaria): Hives that last more than 6 weeks are called chronic urticaria; see a clinician.
Loratadine is generally well tolerated. MedlinePlus lists headache, drowsiness and tiredness as side effects.
Loratadine is an antihistamine: it blocks the action of histamine, which causes allergy symptoms.
5 mg at 2 to under 6 years, 10 mg from 6 years. Convert mg to mL with the bottle strength (1 mg/mL in the US).
It depends on age, once daily: 2 to under 6 years, 5 mg (5 mL of liquid or one 5 mg chewable), no more than 5 mg in 24 hours; 6 years and older, 10 mg (10 mL or two 5 mg chewables), no more than 10 mg in 24 hours. Under 2 years, ask a doctor.
No. The label doses loratadine by age. The calculator above works from weight and caps the result using weight bands that stand in for age (20 kg for 6 years), so check it against the age dose.
Yes. Claritin is a brand of loratadine. Store brands contain the same medicine, but check the strength on the package.
US loratadine liquid is 5 mg/5 mL (1 mg/mL), so 5 mg is 5 mL and 10 mg is 10 mL. Use the enclosed dosing cup.
Only if a doctor directs it. The labels say to ask a doctor for children under 2 years.
It can. The labels warn that taking more than directed may cause drowsiness, and MedlinePlus lists drowsiness and tiredness as side effects.
Some do. The Children's Claritin chewable labels include a phenylketonuria (PKU) warning; check the package if your child has PKU.
Not as a routine treatment. Dermatology guidelines do not recommend non-sedating antihistamines for eczema (atopic dermatitis) unless the child also has hives or hay fever.
Do not combine it with other antihistamines (such as cetirizine, diphenhydramine or hydroxyzine) unless a clinician says to. Tell your doctor or pharmacist about every medicine your child takes.
Children's Claritin Allergy (loratadine) oral solution – Drug Facts
DailyMed (U.S. National Library of Medicine)
SourceChildren's Claritin Chewables 5 mg (loratadine) – Drug Facts
DailyMed (U.S. National Library of Medicine)
SourceDykewicz MS, et al. Rhinitis 2020: A practice parameter update. J Allergy Clin Immunol. 2020;146(4):721-767.
Journal of Allergy and Clinical Immunology
SourceZuberbier T, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-766.
Allergy (Wiley)
SourceLoratadine – MedlinePlus Drug Information
MedlinePlus (U.S. National Library of Medicine)
SourceSidbury R, et al. Guidelines of care for the management of atopic dermatitis: section 3. J Am Acad Dermatol. 2014;71(2):327-349.
Journal of the American Academy of Dermatology
Source